Ketorolac Abc

Ketorolac Trometamol, the active ingredient in Ketorolac Abc, is a Nonsteroidal anti‑inflammatory drug (NSAID) presented as an injectable solution for intramuscular and intravenous use. It is indicated for short‑term management of moderate to severe acute pain, including post‑operative pain, in adult patients.

GNH USA supplies Ketorolac Abc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ketorolac Abc acts on the cyclooxygenase pathway to relieve pain and inflammation. It is clinically employed for: - Acute postoperative pain: provides rapid analgesia after surgical procedures. - Acute musculoskeletal pain: offers short‑term relief of moderate to severe pain from injuries or strains. - Renal colic: delivers effective analgesia for severe flank pain episodes.

Ketorolac may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient pain in the head region. - Dizziness: sensation of light‑headedness or unsteadiness. - Abdominal pain: discomfort in the stomach area. - Injection site pain: local soreness after administration. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Gastrointestinal bleeding: potentially life‑threatening hemorrhage. - Renal impairment: reduced kidney function, especially with prolonged use. - Severe allergic reactions: anaphylaxis, rash, or angioedema. - Stevens‑Johnson syndrome: rare skin disorder with blistering. - Cardiovascular thrombotic events: increased risk of heart attack or stroke. - Hepatic failure: rare liver injury.

Ketorolac should be used with careful assessment of patient risk factors. - Renal function: avoid or adjust dose in patients with impaired kidney function. - Bleeding risk: use cautiously in individuals receiving anticoagulants or with active bleeding. - Gastrointestinal risk: contraindicated in patients with peptic ulcer disease or prior GI bleeding. - Cardiovascular risk: exercise caution in patients with coronary artery disease or hypertension. - Pregnancy and lactation: contraindicated in the third trimester; assess risk‑benefit in earlier stages. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ketorolac can interact with several drug classes, requiring monitoring or avoidance.

Major Interactions (Avoid): - Anticoagulants (warfarin, heparin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - SSRIs and SNRIs: heightened bleeding tendency. - ACE inhibitors and diuretics: potential reduction in renal function. - Lithium: risk of elevated lithium serum levels.

Moderate Interactions (Monitor Closely): - Corticosteroids: increased risk of gastrointestinal ulceration. - Methotrexate: reduced clearance may lead to toxicity.